SCOTT ROCKLAGE’S INPUT TO SCIENCE

Sometimes a good pedigree does not guarantee a good place in life but when one combines it with hard work and determination; they excel beyond their own expectations. Scott Rocklage, an American doctor situated in California is one to attest on the above. He has continued to excel due to his good scientific background and the numerous years of experience and is now one of the very famous people in the field.

 

 

He studied bachelor in science chemistry at the University of California. He later received his Ph.D. in chemistry from Massachusetts Institute of Technology. In the early 1990s he was able to secure a job as company president at Cubist Pharmaceuticals Inc where he worked until 2001. He was able to rise to a chairman and director in the same company, a seat he held until 2004. He also served as its founding CEO from 1994 to 2003. In 1990, he became the president and CEO of Nycomed Salutar, Inc and later become the CEO, chairman and president of Nycomed Interventional in 1992. He joined Achaogen, Inc in 2004 and served as its director until 2015 and Miikana Therapeutics Inc. and Semprus also gave him a role as executive director in the company. He has also served at various leadership positions at Relypsa, Inc., EPIRUS Biopharmaceuticals, Pulmatrix, Inc. and Semprus BioSciences Corp. He is probably among the few people who can perform multi-jobs excellently. Not once did any of the companies complain about any sort of reluctance from him, he is always proactive in all his duties.

 

 

Currently, he works at 5AM Ventures IV, L.P. and 5AM Venture Management LLC as a venture partner since 2003 and became the managing partner in 2004. It is a venture capital firm based in California that seeks to finance early-stage life science companies. It also takes up late stage ventures and private equity investments. Most of the company’s clients consist of medical technology, biopharmaceutical, research instrument and life sciences industries. During his service he was able to raise the company $285 million to its venture capital fund directed towards building of Life science industries. He is also still working with Rennovia, Cidara (NASDAQ: CDTX), Kinestral and on the Boards of Pulmatrix (NASDAQ: PULM) and Epirus (NASDAQ: EPRS).

 

 

Scott Rocklage has gathered years of experience in science that have proven very helpful in his career. With his extensive knowledge he has not only been able to lead numerous companies but also published several peer reviewed publications regarding science and research. He has invented or co-invented 30 patents in U.S. and is now based in the 5AM Ventures’ branch in Boston. His determination to the field of science is exemplary and worth recognition. He is the reason behind many of the enabled scientific and medical researches around the world.

 

 

Leave a Reply

Your email address will not be published. Required fields are marked *